AzTrials
AzTrials

InsomniaRESTEDNCT07121270

Restorative Early Sleep Treatment After the Emergency Department

A study testing Cognitive Behavioral Therapy for Insomnia, Cognitive Behavioral Therapy for Insomnia and Nightmares and Sleep Education in people with Insomnia and Nightmares Associated With Trauma and Stress, run by Henry Ford Health System at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this randomized controlled trial is to pilot the virtual delivery of cognitive behavioral therapy for insomnia (CBT-I) and nightmares (CBT-I\&N) via telehealth as an early intervention for treating posttraumatic sleep disturbance in acute trauma patients exposed to interpersonal violence. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Cognitive Behavioral Therapy for Insomnia, Cognitive Behavioral Therapy for Insomnia and Nightmares and Sleep Education
Could I receive a placebo?
No, everyone receives an active treatment
How many people
80 participants
Where
1 siteUnited States
Study dates
17 Mar 2025to Aug 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Michigan residents treated at Henry Ford Hospital
  • Fluent in English
  • Age 18 years or older
  • Presenting to ED following exposure to Criterion A trauma (exposure to actual or threatened death, serious injury, or sexual violence) characterized by interpersonal violence (defined as any victimization experience that involved being intentionally and directly harmed by another individual
  • i.e., assault with a weapon, physical assault, or sexual assault
  • Qualifying trauma occurred within the past ~72hr
Show all 9Show fewer
  • Hospital Mental Health Risk Screen score ≥ 10 (indicating at-risk for developing mental health problems)
  • Patient is not in any other cognitive behavioral treatment with a master's level clinician or above
  • Patient is appropriate for outpatient treatment and level of acuity does not require inpatient treatment

Who cannot join

  • Presenting to ED for non-interpersonal trauma
  • Defined as any experience that does not involve being intentionally and directly harmed by another individual
  • i.e., falls, motor vehicle collisions, self-injury or suicide attempt
  • Current or past history of schizophrenia or other psychoses based on EMR data
  • Current or past PTSD based on EMR data
  • Unmanaged mania or bipolar disorder based on EMR data
Show all 23Show fewer
  • Active, untreated substance use disorder based on EMR data other than alcohol use disorder, cannabis use disorder, nicotine use disorder, or tobacco use disorder
  • Active suicidality:
  • Presented to ED with self-inflicted injury or attempted suicide
  • Current suicidal ideation with intent (with or without a specific plan) within past month
  • Suicide attempts during the past three months
  • Current homicidal ideation
  • Active substance withdrawal
  • Pregnant
  • Evidence of a current or past traumatic brain injury or loss of consciousness due to head injury at the time of trauma based on EMR data
  • No cell phone, email address, or stable home address
  • Evidence or risk of ongoing traumatic exposure (e.g., domestic violence)
  • Adults in police custody or Dept of Correction patients
  • Evidence of altered mental status, inability to understand study procedures/risks, or otherwise unable to give informed consent
  • Admission to an intensive care unit, admission or surgery, medical instability or hemodynamic compromise
  • Currently engaged in cognitive behavioral treatment
  • Currently living in a nursing home
  • Currently working non-standard shifts (outside the hours 7am - 6pm)

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Anthony Reffi, PhD contact

3138053080

areffi1@hfhs.org

Lily Jankowiak, BS contact

3139165179

ljankow2@hfhs.org

United States1 site, 1 recruiting
  • Henry Ford Hospital System

    Detroit, Michigan, 48202

    Anthony Reffi, PhD, 3138053080, areffi1@hfhs.org

    Lily Jankowiak, BS, 3139165179, ljankow2@hfhs.org

    Recruiting

Other trials in United States

About this study

The goal of this randomized controlled trial is to pilot the virtual delivery of cognitive behavioral therapy for insomnia (CBT-I) and nightmares (CBT-I\&N) via telehealth as an early intervention for treating posttraumatic sleep disturbance in acute trauma patients exposed to interpersonal violence.

The main aims are to:

Read more
  1. Test the acceptability, feasibility, and satisfaction of sleep-focused CBT delivered early after trauma
  2. Evaluate the impact of sleep-focused CBT delivered early after trauma on sleep disturbance
  3. Evaluate the impact of sleep-focused CBT delivered early after trauma on PTSD symptoms

The investigators will compare CBT-I and CBT-I\&N to sleep education control.

Participants will meet with a provider for 6 weekly sessions via telehealth and complete surveys on the participants' symptoms.

Read the detailed description

Participants will be patients who present to Henry Ford Hospital's Emergency Department within >72hr following a potential trauma.

Eligible patients will be randomized (1:1) to the active treatment condition (CBT-I or CBT-I\&N) or to the control condition (sleep education with or without nightmare education).

Patients with insomnia and comorbid nightmares who are randomized to the active treatment condition will be triaged to CBT-I\&N, whereas patients with insomnia and comorbid nightmares who are randomized to the control condition will be triaged to receive sleep education + nightmare education. All other patients with insomnia only will be triaged to receive either CBT-I (active) or sleep education (control).

Being tested
Cognitive Behavioral Therapy for Insomnia, Cognitive Behavioral Therapy for Insomnia and Nightmares, Sleep Education, Sleep Education enhanced with Nightmare Education
Keywords
CBT-I, Nightmares, Insomnia, Trauma, Sleep Education, PTSD, CBT-I&N, Acute Trauma, RCT, Early intervention, Behavioral sleep medicine, Posttraumatic stress, Trauma-induced insomnia, Cognitive behavioral therapy, Prevention
Medical subject headings
Sleep Initiation and Maintenance Disorders, Combat Disorders, Wounds and Injuries, Stress Disorders, Post-Traumatic

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Cognitive Behavioral Therapy for InsomniaBehavioural

    Cognitive Behavioral Therapy for Insomnia (CBT-I) is delivered via 6 weekly 60-min sessions via telemedicine. CBT-I is a multisession treatment approach that focuses on sleep-specific behaviors and thoughts through various methods.

  • Cognitive Behavioral Therapy for Insomnia and NightmaresBehavioural

    Cognitive Behavioral Therapy for Insomnia and Nightmares (CBT-I\&N) is a combination of CBT for Insomnia (CBT-I) and Exposure, Relaxation, and Rescripting Therapy used for the treatment of nightmares (ERRT). CBT-I\&N is delivered via 6 weekly 60-min sessions via telemedicine and includes the modification of sleep habits, exposure, and progressive muscle relaxation.

  • Sleep EducationBehavioural

    Sleep education is delivered via telemedicine via 6 weekly 60-min sessions. These sessions will be focused on psychoeducation on sleep after trauma, including common sleep disturbances that may emerge and sleep hygiene guidelines to minimize these disruptions (e.g., wind-down routine, avoid caffeine).

  • Sleep Education enhanced with Nightmare EducationBehavioural

    Sleep education enhanced with nightmare education will include all the components of normal sleep education, as described above, in addition to normalizing the experience of nightmares after trauma and providing psychoeducation on nightmares. The treatment is provided over 6 weekly 60-min sessions via telemedicine.

Study groups in NCT07121270
Study groupRoleWhat they receive
Cognitive Behavioral TherapyExperimentalCognitive Behavioral Therapy (CBT) is an evidence-based treatment modality that focuses on modifying maladaptive or unhelpful thoughts and behaviors.
Receives: Behavioral: Cognitive Behavioral Therapy for Insomnia; Behavioral: Cognitive Behavioral Therapy for Insomnia and Nightmares
Sleep EducationActive comparatorSleep Education provides general information on human sleep and sleep hygiene guidelines.
Receives: Behavioral: Sleep Education; Behavioral: Sleep Education enhanced with Nightmare Education

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Session Attendance

    Session attendance (# visits attended/# of total visits) ≥ 65% indicates feasibility

    Measured: 1-Week Post-Treatment

  2. Retention Rate

    Retention rate (# CBT patients who completed ≥ 4 sessions/ # randomized to CBT) ≥ 65% indicates acceptability

    Measured: 1-Week Post-Treatment

  3. Patient Satisfaction

    Patient satisfaction with the CBT treatments will be assessed using the Client Satisfaction Questionnaire. Each item is rated on a 1-4 scale, with higher scores indicating greater satisfaction. Mean scores ≥ 3 indicate satisfaction.

    Measured: 1-Week Post-Treatment

  4. Change in Insomnia Symptoms (Insomnia Severity Index)

    The Insomnia Severity Index (ISI) is a commonly used self-report measure of insomnia symptoms. Scores on the ISI range from 0-28, with a higher score indicating greater insomnia severity.

    Measured: From Pre-Treatment to 1-Week Post-Treatment, 1-Month Post-Treatment, and 3-Months Post-Treatment

Secondary outcomes (2)
  1. Change in Nightmare Symptoms (Nightmare Disorder Index)

    The Nightmare Disorder Index (NDI) is a commonly used self-report measure of nightmare severity. Scores on the NDI range from 0-20, with a higher score indicating greater nightmare disorder severity.

    Measured: From Pre-Treatment to 1-Week Post-Treatment, 1-Month Post-Treatment, and 3-Months Post-Treatment

  2. Change in PTSD Symptoms (PTSD Checklist for DSM-5)

    The PTSD Checklist for DSM-5 (PCL-5) is a commonly used self-report measure of PTSD severity. Scores on the PCL-5 range from 0-80, with a higher score indicating greater PTSD severity.

    Measured: From Pre-Treatment to 1-Week Post-Treatment, 1-Month Post-Treatment, and 3-Months Post-Treatment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Aug 2025
  2. Study start17 Mar 2025
  3. Primary completionAug 2027 (estimated)
  4. Study completionAug 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
80 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07121270
Sponsor's protocol ID
17553-01
Acronym
RESTED
Status last verified
Nov 2026
First submitted
21 Jul 2025
Last updated
3 Nov 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Krakow B, Johnston L, Melendrez D, Hollifield M, Warner TD, Chavez-Kennedy D, Herlan MJ. An open-label trial of evidence-based cognitive behavior therapy for nightmares and insomnia in crime victims with PTSD. Am J Psychiatry. 2001 Dec;158(12):2043-7. doi: 10.1176/appi.ajp.158.12.2043.

    PubMed 11729023
  • Ulmer CS, Edinger JD, Calhoun PS. A multi-component cognitive-behavioral intervention for sleep disturbance in veterans with PTSD: a pilot study. J Clin Sleep Med. 2011 Feb 15;7(1):57-68.

    PubMed 21344046
  • Taylor DJ, Pruiksma KE, Mintz J, Slavish DC, Wardle-Pinkston S, Dietch JR, Dondanville KA, Young-McCaughan S, Nicholson KL, Litz BT, Keane TM, Peterson AL, Resick PA; Consortium to Alleviate PTSD. Treatment of comorbid sleep disorders and posttraumatic stress disorder in U.S. active duty military personnel: A pilot randomized clinical trial. J Trauma Stress. 2023 Aug;36(4):712-726. doi: 10.1002/jts.22939. Epub 2023 Jun 15.

    PubMed 37322836

Questions about this trial

What is this clinical trial studying?

A study testing Cognitive Behavioral Therapy for Insomnia, Cognitive Behavioral Therapy for Insomnia and Nightmares and Sleep Education in people with Insomnia and Nightmares Associated With Trauma and Stress, run by Henry Ford Health System at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 23 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 3 Nov 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Anthony Reffi, PhD (3138053080, areffi1@hfhs.org), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Session Attendance (time frame: 1-Week Post-Treatment). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07121270, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in